Darren S Cline - Net Worth and Insider Trading
Darren S Cline Net Worth
The estimated net worth of Darren S Cline is at least $17 Million dollars as of 2024-09-20. Darren S Cline is the EVP, Commercial of Seagen Inc and owns about 72,556 shares of Seagen Inc (SGEN) stock worth over $17 Million. Darren S Cline is also the Director of Pyxis Oncology Inc and owns about 10,000 shares of Pyxis Oncology Inc (PYXS) stock worth over $36,800. Details can be seen in Darren S Cline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Darren S Cline has not made any transactions after 2021-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Darren S Cline
Darren S Cline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Darren S Cline owns 6 companies in total, including Stemline Therapeutics Inc (STML) , GW Pharmaceuticals PLC (GWPH) , and Seagen Inc (SGEN) among others .
Click here to see the complete history of Darren S Cline’s form 4 insider trades.
Insider Ownership Summary of Darren S Cline
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
STML | Stemline Therapeutics Inc | 2020-06-10 | director |
GWPH | GW Pharmaceuticals PLC | 2020-06-04 | U.S. Chief Commercial Officer |
SGEN | Seagen Inc | 2018-11-29 | EVP & Commercial |
2021-12-08 | director | ||
2023-03-06 | director | ||
2023-04-12 | director |
Darren S Cline Latest Holdings Summary
Darren S Cline currently owns a total of 2 stocks. Among these stocks, Darren S Cline owns 72,556 shares of Seagen Inc (SGEN) as of November 29, 2018, with a value of $17 Million and a weighting of 99.78%. Darren S Cline also owns 10,000 shares of Pyxis Oncology Inc (PYXS) as of December 8, 2021, with a value of $36,800 and a weighting of 0.22%.
Latest Holdings of Darren S Cline
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2018-11-29 | 72,556 | 228.74 | 16,596,459 |
PYXS | Pyxis Oncology Inc | 2021-12-08 | 10,000 | 3.68 | 36,800 |
Holding Weightings of Darren S Cline
Darren S Cline Form 4 Trading Tracker
According to the SEC Form 4 filings, Darren S Cline has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 7,000 shares on November 29, 2018, which brought Darren S Cline around $440,160.
According to the SEC Form 4 filings, Darren S Cline has made a total of 1 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pyxis Oncology Inc is the acquisition of 10,000 shares on December 8, 2021, which cost Darren S Cline around $93,900.
Insider Trading History of Darren S Cline
- 1
Darren S Cline Trading Performance
GuruFocus tracks the stock performance after each of Darren S Cline's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Darren S Cline is -51.76%. GuruFocus also compares Darren S Cline's trading performance to market benchmark return within the same time period. The performance of stocks bought by Darren S Cline within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Darren S Cline's insider trading performs compared to the benchmark.
Performance of Darren S Cline
Darren S Cline Ownership Network
Darren S Cline Owned Company Details
What does Stemline Therapeutics Inc do?
Who are the key executives at Stemline Therapeutics Inc?
Darren S Cline is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .
Stemline Therapeutics Inc (STML) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stemline Therapeutics Inc Insider Transactions
Darren S Cline Mailing Address
Above is the net worth, insider trading, and ownership report for Darren S Cline. You might contact Darren S Cline via mailing address: 35 Cambridge Park Drive, Cambridge Ma 02140.